University of Eastern Finland, Dpet of Public Health and Clinical Nutrition
Kuopio, FIN-70211, Finland
NCT Number: NCT01414647
Dietary polyphenols might have beneficial effects on glucose and lipid metabolism based on the studies made in animals or cell cultures. The findings regarding the possible decrease of low-grade inflammation are existing also in humans. Low-grade inflammation has been suggested to be a mechanistic link between obesity and its consequences on cardiometabolic health. The aim of the present study is to examine the effect of diet rich in berries on glucose and lipid metabolism and inflammatory markers.
Looking for future studies?
Notify Me50 year–65 year
All sexes
Interventional
Not applicable
Kuopio, FIN-70211, Finland
Berries are traditionally an important part of the Nordic diet. About 50 different berries are grown in the northern region, and about half of them are edible. Phenolic compounds are one of the most diverse group of secondary metabolites present in edible plants, and berries are especially rich in them. Flavonoids, phenolic acids, lignans and complex phenolic polymers (polymeric tannins) are typical for berries. Phenolic compounds are reported to have a variety of beneficial biological properties. They are potent antioxidants, and exhibit various other physiological activities including anti-inflammatory, antimicrobial, antiallergic, anticarcinogenic and antihypertensive activities. Epidemiological studies indicate that diet rich in phenolic compound correlates with lower risk of cancer and cardiovascular disease.
The aim of the present study is to examine the effect of diet rich in berries on glucose and lipid metabolism and inflammatory markers and gene expression profile in peripheral blood mononuclear cells (PBMCs) in subjects with features of metabolic syndrome.
Randomized, controlled clinical intervention including 4 wk run-in period, 8 wk dietary intervention and 4 wk recovery period was conducted.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
100 g of strawberry puree, 100 g of frozen raspberries and 100 g frozen cloudberries were concumed daily for 8 weeks. Bilberry consumption was restricted.
Equivalent amount to 400 g of fresh bilberries were consumed as 40 g of dried bilberries and as 200 g of frozen bilberries. Restriction of use of strawberries, raspberries and cloudberries were set.
Control diet, ie. habitual diet with restriction of berry consumption was consumed for eight weeks
Other names: Diet with restricted consumption of berries.
Time frame: week 8
Fasting glucose level oral glucose tolerance status at study week 8
Time frame: week 8
total, HDL and LDL cholesterol level at the study week 8
Time frame: week 8
Various inflammation markers were measured at the study week 8
Time frame: week 8
Markers of cholesterol absorption and synthesis were measured
Time frame: study week 8
Global gene expression analyses in peripheral mononuclear cells (PBMC)
Marjukka Kolehmainen
Other
The Effect of Diet Rich in Nordic Berries on Gut Microbiota, Glucose and Lipid Metabolism and Metabolism on Fenolic Compounds
Acronym: Berry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07703371
Body Weight, Dyslipidemia
Mysore, Karnataka, India
View Trial DetailsNCT02037321
Arthritis, Body Weight
Toronto, Ontario, Canada
View Trial DetailsNCT03241121
Behavior, Behavior, Animal
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT06626867
Body Weight, Cardiovascular Diseases
Taipei, Taiwan
View Trial Details